The Epharmix research network comprises independent clinical researchers at top universities using the Epharmix technology platform to translate behavioral science research to improved clinical outcomes.

Clinical Advisors

Epharmix stands on the shoulders of giants. Our advisors include practicing physicians, chief medical officers, and medical professionals in specialties ranging from Cardiology, Nephrology, Pulmonolgy, and more.







Bruce R. Bacon
Laura J. Bierut
Brenda Bingel
Kristina Bonacker

Madeleine Chollet
Kelly Dodds
Gregory Ewald
Cindy Lefton

Sean Rodriguez
Carol Scott
Adrian Shifren
Terri St. John

Independence

All Epharmix research is conducted by clinical researchers across the nation
at leading academic and community institutions.



Institutions
  • University of California, San Francisco (UCSF)
  • Stanford University
  • Texas A & M
  • Ohio State University
  • University of Maryland
  • University of Connecticut
  • Saint Louis University School of Medicine
  • Washington University School of Medicine in St. Louis

Outcomes

Epharmix Interventions:
Designed by Expert Physicians | Clinically Validated at Top Institutions

The Epharmix clinical team designs, develops, and tests each intervention to improve health outcomes and increase patient engagement. See how Epharmix interventions have enhanced the following areas:

Geriatrics
EpxFallPrevention
Fall tracking service for identifying fall risks early.
 
One out of three older adults falls each year1 but less than half talk to their healthcare providers about it2. With EpxFallPrevention, 75% of pateints notified their doctor of a fall.

1. Tromp AM, Pluijm SMF, Smit JH, et al. Fall-risk screening test: a prospective study on predictors for falls in community-dwelling elderly. J Clin Epidemiol 2001;54(8):837–844.
2. Stevens JA, Ballesteros MF, Mack KA, Rudd RA, DeCaro E, Adler G. Gender differences in seeking care for falls in the aged Medicare Population. American Journal of Preventive Medicine 2012;43:59–62.
Pulmonology
EpxCOPD
Breathing quality tracking and activation assessment for COPD patients.
EpxCOPD study shows improved breathing scores and sustained patient response rate of 80% on average over 120 days.
fig. 1 By monitoring acute triggers (when patient reports breathing worse),
 the nurse practitioner can engage and intervene before further complication develops. Throughout the study the average normalized breathing score sees a consistent increase over time.
fig. 2 During the period of the study, the response rate across patient population is consistently ranged between 60% - 100%, showing no obvious message fatigue.
Nephrology
EpxDialysis
Dialysis reminder and adherence service.
fig. 1 a) Before the trial starts, the average numbers of missed dialysis sessions per patient per month for both cohorts are approximately equal. b) Once trial starts in February, the cohort receiving EpxDialysis missed significantly fewer sessions than the control cohort. c) When the cross-over occurs in April, the control cohort, now receiving EpxDialysis, sees a decrease in missed sessions, while the cohort that is no longer receiving EpxDialysis sees an increase in missed sessions.
fig. 2 describes the % of patients who were hospitalized during the study period. Hospitalizations were reduced by 54% (54.4% patients were hospitalized in the control cohort, and 25% of patients were hospitalized in the EpxDialysis cohort)

Join the Epharmix Research Network

Join the Epharmix Research Network

“We have been able to include older adults who are legally blind in our study as a result of this service. We didn't need to convert our study measures to braille. The ability to be connected with with study staff immediately... will likely improve the quality of our data.”



Susan Stark

Susan Stark, OT, PhD

Professor of Occupational Therapy
Washington University School of Medicine


Study the latest in digital health with Epharmix

Divisions

Principal Investigators
Kelly Dodds
Gregory Ewald


Epharmix Clinical Researchers

Disease States

EpxCOPD

Breathing quality tracking and activation assessment for patients with COPD.

EpxDiabetes

Preprandial blood glucose monitoring for patients with diabetes.

EpxDialysis

Dialysis adherence service.

EpxFallPrevention

Fall tracking service for identifying fall risks early.

EpxHeartFailure

A symptom tracking intervention for patients with heart health issues.

EpxHypertension

Blood pressure tracking for patients with hypertension.

EpxMood

Mood tracking for patients with bipolar and depression.

Principal Investigators
Terri St. John
Epharmix Clinical Researchers
Disease States

EpxDecolonization

Ensures and helps patients undergo decolonization for orthopedic and other types of surgery.

EpxSurgery

A versatile suite of pre-op and post-op follow-ups for a wide range of surgery types.

EpxWound

Post surgery follow up to detect the first signs of infection.

Principal Investigators
Epharmix Clinical Researchers
Molly Henson
Antoinette Hu

Mary Ising

Disease States

EpxBreastfeeding

Breastfeeding adherence service.

EpxGestationalDiabetes

Blood glucose monitoring for pregnant patients with diabetes.

EpxPostPartumDepression

Postpartum Depression screening application

EpxPostPartumFollowUp

Ensures and helps patients follow-up with a provider after delivery.

Principal Investigators
Epharmix Clinical Researchers

Disease States

EpxMood

Mood tracking for patients with bipolar and depression.

EpxPostPartumDepression

Postpartum Depression screening application

Epharmix Clinical Researchers
Disease States

EpxDischargeReferral

Discharge referral program for patients.

EpxMedicationTracking

A medication adherence tracking system for patients.

Principal Investigators
Gregory Ewald
Epharmix Clinical Researchers

Disease States

EpxDialysis

Dialysis adherence service.

EpxDischargeReferral

Discharge referral program for patients.

EpxHeartFailure

A symptom tracking intervention for patients with heart health issues.

EpxMedicationTracking

A medication adherence tracking system for patients.

Performance Pricing

Our success is your success. We stand behind our research. Epharmix takes risk with you.

Request a Quote

Join our newsletter to get the latest news about digital health and remote patient monitoring.